DQA1*03011 allele: Protective or an adverse effect on the development of sarcoidosis; preliminary study

Respiratory Medicine

Volumn 101, Issue 10, 2007, Pages 2213-2216

  Dubaniewicz, Anna ^a   Dubaniewicz, Andrzej ^b   Dubaniewicz, Ada ^a   Moszkowska, Grazyna ^a  

^a MEDICAL UNIVERSITY OF GDANSK   (Poland)

^b Ceynowy's Hospital Poland   (Poland)

Author keywords

DQA1*03011; Sarcoidosis; Tuberculosis

Indexed keywords

HLA DQA1 ANTIGEN; HLA ANTIGEN;

ADULT; AGED; ARTICLE; BACTERIUM CULTURE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; GENE FREQUENCY; GENE IDENTIFICATION; GENE LOCUS; GENETIC PREDISPOSITION; GENETIC RISK; GENOTYPE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LUNG SARCOIDOSIS; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PATHOGENESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RISK ASSESSMENT; VOLUNTEER; ALLELE; COMPARATIVE STUDY; GENETIC POLYMORPHISM; GENETICS; IMMUNOLOGY; SARCOIDOSIS;

ADULT; ALLELES; FEMALE; GENE FREQUENCY; GENOTYPE; HLA ANTIGENS; HUMANS; MALE; POLYMORPHISM, GENETIC; SARCOIDOSIS, PULMONARY;

EID: 34548200758     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rmed.2007.06.004     Document Type: Article

References (13)

1. American Thoracic Society. Statement on sarcoidosis. Am J Respir Crit Care Med 160 (1999) 735-736
2. Dubaniewicz A., Moszkowska G., and Szczerkowska Z. Analysis of frequency of DRB1-DQB1 two-locus haplotypes in tuberculosis; preliminary report. Tuberculosis (Edinb) 85 (2005) 259-267
3. Sharma S.K., Balamurugan A., Pandey R.M., Saha P.K., and Mehra N.K. Human leukocyte antigen--DR alleles influence the clinical course of pulmonary sarcoidosis in Asian Indians. Am J Respir Cell Mol Biol 29 (2003) 225-231
4. Berlin M., Fogdell-Hahn A., Olerup O., Eklund A., and Grunewald J. HLA-DR predicts the prognosis in Scandinavian patients with pulmonary sarcoidosis. Am J Respir Crit Care Med 56 (1997) 1601-1605
5. Ishihara M., Ohno S., Ishida T., et al. Molecular genetic studies of HLA class II alleles in sarcoidosis. Tissue Antigens 43 (1994) 238-241
6. Rutherford R.M., Kearns M., Bourke M., Stevens F., and Gilmartin J.J. HLA-DR2 predicts susceptibility and disease chronicity in Irish sarcoidosis patients. Sarcoidosis Vasc Diffuse Lung Dis 21 (2004) 191-198
7. Boytim M.L., Lyu S.C., Jung R., Krensky A.M., and Clayberger C. Inhibition of cell cycle progression by a synthetic peptide corresponding to residues 65-79 of an HLA class II sequence: functional similarities but mechanistic differences with the immunosuppressive drug rapamycin. J Immunol 160 (1998) 2215-2222
8. Ling X., Kamangar S., Boytim M.L., et al. Proliferating cell nuclear antigen as the cell cycle sensor for an HLA-derived peptide blocking T cell proliferation. J Immunol 164 (2000) 6188-6192
9. Boytim M.L., Lilly P., Drouvalakis K., et al. A human class II MHC-derived peptide antagonizes phosphotidylinositol 3-kinase to block IL-2 signaling. J Clin Invest 105 (2000) 1447-1453
10. Dong C., Lyu S.H., Krensky A.M., and Clayberger C. DQ65-79, a peptide derived from HLA class II, mimics p21 to block T cell proliferation. J Immunol 171 (2003) 5064-5070
11. Claus R., Werner H., Schulze H.A., Walzel H., and Friemel H. Are soluble monocyte-derived HLA class II molecules candidates for immunosuppressive activity?. Immunol Lett 26 (1990) 203-210
12. Nossner E., Goldberg J.E., Naftzger C., Lyu S.C., Clayberger C., and Krensky A.M. HLA-derived peptides which inhibit T cell function bind to members of the heat-shock protein 70 family. J Exp Med 183 (1996) 339-348
13. Murphy B., Magee C.C., Alexander S.I., et al. Inhibition of allorecognition by a human class II MHC-derived peptide through the induction of apoptosis. J Clin Invest 103 (1999) 859-867